Biotech

All Articles

Boundless Bio creates 'moderate' cutbacks 5 months after $100M IPO

.Simply 5 months after getting a $100 million IPO, Boundless Bio is actually already giving up some ...

Halda's $126M will definitely evolve 'hold and also kill' tumor drugs

.The preliminary stages of oncology R&ampD aren't except fascinating brand-new methods, as well as H...

Lykos 'regrets' not divulging research study infractions along with author

.Psychopharmacology has drawn 3 short articles regarding midstage clinical test data determining Lyk...

Analysts explore Avidity's DMD win, uncovering nuances in data

.Avidity Biosciences pleased entrepreneurs along with period 1/2 data in Duchenne muscle dystrophy (...

Actinogen's cortisol blocker falls short phase 2 anxiety research

.Actinogen Medical's cortisol blocker has actually skipped the main endpoint of a phase 2 study in d...

Bivictrix decides going personal only way to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have been at the facility of numerous a billion-dollar biobuck lice...

TPG tops up funds to $580M for financial investments all over life sciences

.Asset manager TPG, which has actually assisted biotechs including Sionna Therapeutics and also Sant...

Merck ceases stage 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT system has actually endured another trouble. Months after shuttering a phase...

After a difficult year, Exscientia folds in to Recursion

.After a year specified by pipeline cuts, the variation of its CEO as well as discharges, Exscientia...

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Rehab was actually made an impression on sufficient with Port BioMed's bispecific invulner...